DLRHX
Price
$24.54
Change
+$0.26 (+1.07%)
Updated
Sep 5 closing price
Net Assets
668M
JFNIX
Price
$70.64
Change
+$0.56 (+0.80%)
Updated
Sep 5 closing price
Net Assets
4.28B
Interact to see
Advertisement

DLRHX vs JFNIX

Header iconDLRHX vs JFNIX Comparison
Open Charts DLRHX vs JFNIXBanner chart's image
Macquarie Healthcare R
Price$24.54
Change+$0.26 (+1.07%)
VolumeN/A
Net Assets668M
Janus Henderson Global Life Sciences I
Price$70.64
Change+$0.56 (+0.80%)
VolumeN/A
Net Assets4.28B
DLRHX vs JFNIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DLRHX vs. JFNIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLRHX is a Buy and JFNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.29B vs. DLRHX (668M). JFNIX pays higher dividends than DLRHX: JFNIX (0.39) vs DLRHX (0.00). DLRHX was incepted earlier than JFNIX: DLRHX (16 years) vs JFNIX (16 years). DLRHX (1.50) is less costly to investors than JFNIX (0.77). JFNIX is a more actively managed with annual turnover of: 35.00 vs. DLRHX (5.00). DLRHX has a lower initial minimum investment than JFNIX: DLRHX (0) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -12.88 vs. DLRHX (-14.61). JFNIX return over 5 years is better than : 10.19 vs. DLRHX (-7.00).
DLRHXJFNIXDLRHX / JFNIX
Total Expense Ratio1.460.77190%
Annual Report Gross Expense Ratio1.500.77195%
Fund Existence16 years16 years-
Gain YTD6.5573.852170%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets668M4.29B16%
Annual Yield % from dividends0.000.39-
Returns for 1 year-14.61-12.88113%
Returns for 3 years1.9817.0212%
Returns for 5 years-7.0010.19-69%
Returns for 10 years24.8122.06113%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJPTX14.960.14
+0.94%
VY® JPMorgan Emerging Markets Equity S2
PGLEX19.150.09
+0.47%
Putnam Focused International Equity R6
FFANX13.970.04
+0.29%
Fidelity Asset Manager 40%
OMGCX27.10N/A
N/A
JPMorgan Mid Cap Growth C
AFAVX14.42N/A
N/A
AMG River Road Focused Absolute Value I